Prevention of post procedural acute kidney injury in the catheterization laboratory in a real-world population
Ehud Chorin(Ben-Gurion University of the Negev), Shmuel Banai(Tel Aviv Sourasky Medical Center), Yaron Arbel(Tel Aviv Sourasky Medical Center), Ilan Rabey(Tel Aviv University), Eyal Ben–Assa(Massachusetts General Hospital), Jeremy Ben Shoshan(Tel Aviv University), Samuel Bazan(Tel Aviv University), Naama Galli(Tel Aviv University), Maayan Konigstein(Tel Aviv University), Aviram Hochstadt(Tel Aviv University), Maytal Rofe(Tel Aviv University), Ariel Finkelstein, Gad Keren(Assuta Medical Center), Michael Schnapper(Tel Aviv University), Itzhak Herz(Tel Aviv University), Amir Halkin(Tel Aviv University)
Cited by 19
Related Papers
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|731
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|646
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
|Atherosclerosis|2012|390
Role of Naturally Occurring CD4 <sup>+</sup> CD25 <sup>+</sup> Regulatory T Cells in Experimental Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2007|347